CN1143495A - Ointment for eliminating tinea - Google Patents
Ointment for eliminating tinea Download PDFInfo
- Publication number
- CN1143495A CN1143495A CN 95111936 CN95111936A CN1143495A CN 1143495 A CN1143495 A CN 1143495A CN 95111936 CN95111936 CN 95111936 CN 95111936 A CN95111936 A CN 95111936A CN 1143495 A CN1143495 A CN 1143495A
- Authority
- CN
- China
- Prior art keywords
- ointment
- tinea
- medicine
- norfloxacin
- dexamethasone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
An ointment for curing tinea corporis, favus of the scalp, tinea manuum, tinea pedis and onychomycosis contains clotrimazole, griseofulvin, phenergan, dexamethasone, chlorpheniramine, norfloxacin, and white vaseline and features short course of treatment (4-5 weeks), high effective rate (100%) and cure rate (more than 95%) and no recurrence.
Description
The present invention relates to the tinea ointment of a kind of treatment and removal body, head, hands, foot, tinea unguium.
The tinea cream of present known treatment body, head, hands, foot, tinea unguium has multiple, as: JIAOXIAN YICIJING, miconazole, Ge Hong beriberi liquor, clotrimazole tinea liquid etc., therapeutic effect is undesirable, and the course of treatment is long, serious symptom can not be effected a radical cure, and particularly this class stubborn dermatitis disease of weevil tinea more is difficult to cure; The medicine that has is big to skin irritation, and relapse rate is higher, as the Ge Hong beriberi liquor, till settled the present, does not also have a kind of ideal medicament that can effect a radical cure above-mentioned tinea class.
The purpose of this invention is to provide and a kind ofly can fast and effeciently effect a radical cure the medicine of body, head, hands, foot, tinea unguium, control no longer recurrence behind Yu simultaneously, without any side effects to human body.
The present invention utilizes known western proprietary assembly to make, and it is made up of following medicine components: (every hectogram ointment contains the medicine component)
Clotrimazole 1~3g
Griseofulvin 1~3g
Promethazine 0.1~0.5g
Dexamethasone 0.006~0.015g
Chlorphenamine 0.02~0.05g
Norfloxacin 0.5~2g
Surplus is medical petrolatum oil (being added to 100g)
The medicine grinding of above-mentioned amount is made ointment with the vaseline oil mixing, and the coating affected part gets final product.
The present invention compares with existing similar medicine has following advantage:
1, short treating period, cure rapidly, general tinea corporis or patient with slight symptoms's 1~2 week recovery from illness, ringworm 4~5 week recovery from illness that serious symptom or tinea unguium class refractory are healed: safety non-toxic, nonirritant, can suppress tinea bacteria growing, antipruritic, antiinflammatory, good analgesic effect quickly and effectively, promote the histiocyte regeneration function, dermatophytes is had extremely strong killing action, and effective percentage be 100%, cure rate is more than 95, no longer recurrence after the healing:
2, preparation is easy, easy to use, and formulation rate is few, and significant curative effect is promptly arranged in a short time.
Below in conjunction with specific embodiment the present invention is made a detailed description.
Embodiment 1:
Get 5 of clotrimazole sheets, every contains clotrimazole 0.2g; 5 of griseofulvin tablets, every contains griseofulvin 0.2g; 8 of promethazines, every contains promethazine 0.025g; 16 of dexamethasone, every contains 0.75 milligram of dexamethasone; 8 of chlorphenamines, every contains 5 milligrams of chlorphenamines; Norfloxacin glue is assisted 10, and every contains norfloxacin 0.1g; 6 kinds of medicines are ground to form 120~200 order fine powders and Bai Fanlin oil 96.748g mixing make ointment, the coating affected part gets final product.
Embodiment 2:
Get clotrimazole 2g, griseofulvin 2g, promethazine 0.4g, dexamethasone 0.015g, chlorphenamine 0.04g, norfloxacin 1g grinds to form 120~200 order fine powders with 6 kinds of medicines and white vaseline oil 94.545g mixing is made unguentum, spreads on the affected part and gets final product.
Claims (1)
1, a kind of ointment for the treatment of body, head, brothers, tinea unguium is characterized in that it is made up of following medicine components: (every hectogram ointment contains the medicine component)
Clotrimazole 1~3g
Griseofulvin 1~3g
Promethazine 0.1~0.5g
Dexamethasone 0.006~0.015g
Chlorphenamine 0.02~0.05g
Norfloxacin 0.5~2g
Surplus is medical petrolatum oil (being added to 100g)
Above-mentioned amount medicine grinding is hybridly prepared into ointment with medical petrolatum oil.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95111936A CN1062128C (en) | 1995-08-18 | 1995-08-18 | Ointment for eliminating tinea |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95111936A CN1062128C (en) | 1995-08-18 | 1995-08-18 | Ointment for eliminating tinea |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1143495A true CN1143495A (en) | 1997-02-26 |
CN1062128C CN1062128C (en) | 2001-02-21 |
Family
ID=5079169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95111936A Expired - Fee Related CN1062128C (en) | 1995-08-18 | 1995-08-18 | Ointment for eliminating tinea |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1062128C (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100348202C (en) * | 2005-04-28 | 2007-11-14 | 刘朝雄 | Oral compound preparation for treating skin disease |
CN106580929A (en) * | 2016-12-02 | 2017-04-26 | 贺敏 | Skin disease medicine composition, preparation method and application thereof |
CN110354134A (en) * | 2019-08-29 | 2019-10-22 | 周德文 | A kind of ointment and preparation method thereof for treating chronic inflammation anaphylaxis dermatosis |
CN110559259A (en) * | 2019-09-23 | 2019-12-13 | 郭小兵 | plaster for treating intractable skin diseases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1019929C (en) * | 1990-03-21 | 1993-02-24 | 朱晏 | Preparation method of norfloxacin beriberi water |
CN1021798C (en) * | 1990-12-19 | 1993-08-18 | 大连市医药科学研究所 | Preparation process of tinea-removing film coating agent |
-
1995
- 1995-08-18 CN CN95111936A patent/CN1062128C/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100348202C (en) * | 2005-04-28 | 2007-11-14 | 刘朝雄 | Oral compound preparation for treating skin disease |
CN106580929A (en) * | 2016-12-02 | 2017-04-26 | 贺敏 | Skin disease medicine composition, preparation method and application thereof |
CN110354134A (en) * | 2019-08-29 | 2019-10-22 | 周德文 | A kind of ointment and preparation method thereof for treating chronic inflammation anaphylaxis dermatosis |
CN110559259A (en) * | 2019-09-23 | 2019-12-13 | 郭小兵 | plaster for treating intractable skin diseases |
Also Published As
Publication number | Publication date |
---|---|
CN1062128C (en) | 2001-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109646712B (en) | Colloidal sulfur liquid dressing and preparation method thereof | |
US20220183951A1 (en) | Skin treatment methods and compositions with retinoid and delivery systems thereof | |
Samarh et al. | Evidence based medical use of aloe vera extracts, short review of literature | |
CN101612278B (en) | Medicine for external application for treating pyogenic type contaminated wounds | |
CN1062128C (en) | Ointment for eliminating tinea | |
EP2260853A3 (en) | Biocompatible polymers for a medical composition | |
JP2798287B2 (en) | Anti-inflammatory agent | |
CN1224406C (en) | Medical ointment Jiaoxuanxiao for treating beriberi | |
CN102526494B (en) | Ointment for treating burning | |
CN1911231A (en) | Medicine for treating burns | |
CN1093923A (en) | Wound, ulcer loose | |
CN107929098A (en) | A kind of cosmetics and skincare product and the pharmaceutical composition for treating burn and scald | |
CN1057467C (en) | Medicine for treating impetigo | |
CN115844784B (en) | Composition for relieving inflammation of dry skin and application and preparation method thereof | |
CN1105561C (en) | Medicine for treating bromhidrosis and beriberi | |
CN1247204C (en) | Medicine for treating beri-beri | |
JPH1160494A (en) | Preparation for preventing recurrence of atopic dermatitis | |
CN1086125C (en) | Externally used medicine for treating tinea | |
CN1706381A (en) | Frostbite and chilblain treating ointment | |
Fabrizi et al. | Calcipotriol and psoriasis in children | |
CN1056987C (en) | Medicine for curing viral warts | |
CN112121062A (en) | External-use medicine composition for treating bromhidrosis | |
CN1245071A (en) | Medicine for treating cervical erosion | |
CN115054614A (en) | Facial cleansing cream for radically treating facial acne and preparation method thereof | |
CN116059239A (en) | Composition containing cannabidiol and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |